Skip to Content

CNN – Health

The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine

Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine

By Jacqueline Howard, CNN The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine, CEO Stanley Erck told CNN in a phone interview Friday. “We’ll have a file in the US hopefully before the end of the year,” Erck

Continue Reading
Even if they get a breakthrough infection

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the spread

Continue Reading
Even if they get a breakthrough infection

Even if they get breakthrough infections, vaccinated people don’t get as sick with Covid-19, studies show

By Maggie Fox, CNN Even if they get a breakthrough infection, vaccinated people don’t get as sick with Covid-19, two different teams of researchers reported Thursday. Both studies show the vaccines strongly protect against severe disease and death, even months after people were first vaccinated and as the more transmissible Delta variant renewed the spread

Continue Reading
The UK Medicines and Healthcare Products Regulatory Agency said on November 4 it had authorized Merck and Ridgeback Biotherapeutics' oral antiviral

UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19

By Jamie Gumbrecht, CNN The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. It is the world’s first oral antiviral to be authorized anywhere for the treatment of Covid-19. The drug comes in

Continue Reading
The next step in vaccinating children is families finding the nearest dose. Tyann Davis holds her son Cameron Davis' hand as IHA Plymouth Pediatrics Medical Assistant Madison Peterson gives him the Pfizer Covid-19 vaccine.

Pediatrician or pharmacy? Expert weighs in on how to get a Covid vaccine appointment for your child

By Madeline Holcombe, CNN Now that health officials in the US have issued emergency use authorization for a vaccine for younger children, the next step in vaccinating children is families finding the nearest dose. The US Centers for Disease Control and Prevention recommended Tuesday that children ages 5 to 11 get a version of Pfizer-BioNTech’s

Continue Reading